HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece

Nov.15.2024
 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
HAYATI launches new Hayati® Mini Ultra disposable vape in UK, featuring two 2ml transparent e-liquid pods with different flavours, allowing users to switch flavours by twisting the mouthpiece, providing approximately 1500 puffs.

Disclaimer

 

  • This article is intended solely for internal industry communication and does not constitute an endorsement of any brand or product.
  • The images presented in this article are for factual illustration purposes only and should not be interpreted as advertisements for any product.
  • Access to this article is prohibited for minors.

 

Recently, 2Firsts noticed that the vape brand HAYATI has launched the Hayati® Mini Ultra vape in the UK market. The product features two 2ml pods, compliant with TPD standards, and offers approximately 1500 puffs.

 

Specifically, the product features of the Hayati® Mini Ultra include:

 

 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
Hayati® Mini Ultra parameters | Plotting: 2Firsts

 

The main feature of the Hayati® Mini Ultra is its ability to hold two 2ml transparent e-liquid pods with different flavours, allowing users to switch between the two flavours by twisting the mouthpiece.

 

 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
Hayati® Mini Ultra | Image source: vapesourcing

 

Previously, the HAYATI brand launched the Hayati® PRO Ultra vape, which also features a similar twist mouthpiece design. However, this product is equipped with two 12ml e-liquid pods and claims to provide approximately 15,000 puffs.

 

 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
HAYATI® Pro Ultra Disposable 15,000 Puffs|Image Source: HAYATI Official Website

 

It is worth noting that the Hayati® Mini Ultra does not feature the electronic screen used in the Hayati® PRO Ultra for direct battery level display. Instead, it uses a color-changing "lotus-shaped" LED indicator to indirectly show the battery level.

 

Currently, the Hayati® Mini Ultra is available on the official HAYATI website and other well-known UK vape retailers like vapesourcing.uk, with the product page marked as "COMING SOON."

 

 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
Hayati® Mini Ultra Product Page | Image Source: vapesourcing

 

According to the official HAYATI website, the HAYATI brand is owned by PAX Innovations (Shenzhen) Limited. All product registration applications with the UK Medicines and Healthcare Products Regulatory Agency (MHRA) are submitted by this company. The HAYATI website also references "PAX Manufacturing" and includes a link to the corresponding website.

 

 HAYATI Launches 2-in-1 Product in the UK with Twist Mouthpiece
PAX official website | Image source: PAX

 

The PAX official website states that the company was founded in Hong Kong in 2021. Its founder, Mr. He, is an experienced expert in the e-cigarette industry, dedicated to the research and innovation of e-cigarette products.

 

2Firsts will continue to track the latest products and market trends in disposable vapes, offering the public accurate and authoritative industry information.

 


 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei Industrial Co., Ltd. disclosed several oral nicotine-related patent applications in August 2026, including two that approach staged nicotine release from different directions. One uses a high-viscosity membrane that forms inside the pouch after contact with saliva to slow rapid early release, while the other uses gradient particles with a faster-disintegrating outer layer and a slower core to create a fast-to-sustained release profile. Together, the filings explore how nicotine pouches could balance initial delivery with release later in use.
Sep.03
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09